Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF)
(“
RWB” or the “
Company”) and
Aleafia Health Inc. (TSX: AH and OTCQB:
ALEAF) (“
Aleafia”) are announcing the mutual
termination of the binding letter agreement entered into between
the parties on June 6, 2023 (the “
Letter
Agreement”) in respect of the proposed business
combination transaction (the “
Proposed
Transaction”), as detailed in the joint press release
issued on June 7, 2023. The termination is without liability or
cost to either party.
Pursuant to the Letter Agreement, and as a
pre-requisite to closing the previously announced Proposed
Transaction, the approval of holders of Aleafia convertible
debentures issued under the amended and restated debenture
indenture providing for the issue of certain convertible debentures
dated as of June 27, 2022 between Aleafia and Computershare Trust
Company of Canada, as the trustee, as supplemented by: (a) the
first supplemental indenture dated as of June 27, 2022 (providing
for the issue of the 8.5% Series A Secured Convertible Debentures
Due June 30, 2024); (b) the second supplemental indenture dated as
of June 27, 2022 (providing for the issue of the 8.5% Series B
Secured Convertible Debentures Due June 30, 2026), and (c) the
third supplemental indenture dated as of June 27, 2022 (providing
for the issue of 8.50% Series C Secured Debentures Due June 30,
2028) (collectively, the “Aleafia Convertible
Debentures”) was required to settle all outstanding
amounts due to them for an aggregate amount of $6 million in
exchange for the cancellation of all Aleafia Convertible
Debentures.
While Aleafia had received support in writing
from certain holders of the outstanding Aleafia Convertible
Debentures, certain other holders representing more than 33 1/3% of
the outstanding Aleafia Convertible Debentures, as represented by
their designated representatives, have communicated to Aleafia and
RWB that they will not accept the terms of the settlement set out
in the Letter Agreement. As a result, a key condition of the
Proposed Transaction cannot be satisfied and the parties have
mutually agreed to terminate the Letter Agreement.
Pursuant to an assignment of indebtedness and
security dated June 6, 2023, NE SPC II LP sold to RWB, all
indebtedness of Aleafia and certain of its affiliates in connection
with the loan agreement made as of December 24, 2021, as amended on
March 28, 2022, June 17, 2022, April 26, 2023, May 15, 2023, and
May 31, 2023 (the “Aleafia Senior Secured Loan
Agreement”). Aleafia is currently in breach of certain
covenants under the Aleafia Senior Secured Loan Agreement, and
while RWB has not, to date, taken steps to formally note Aleafia in
default or immediately enforce its security, RWB has not waived any
outstanding breaches and has reserved all of its rights and
remedies under the Aleafia Senior Secured Loan Agreement and
related security. RWB is currently considering all available
options.
As a result of the termination of the Letter
Agreement, and in light of the status of the Aleafia Senior Secured
Loan Agreement, disinterested members of the board of directors of
Aleafia continue to explore and evaluate potential strategic
alternatives that may be available to Aleafia with the goal of
maximizing value for Aleafia stakeholders. Aleafia
does not intend to comment further with respect to the
ongoing strategic review process unless and until it determines
that additional disclosure is appropriate in the circumstances and
in accordance with applicable securities laws.
About Red White & Bloom Brands
Inc.
Red White & Bloom is a multi-state cannabis
operator and house of premium brands in the U.S. legal cannabis
sector. RWB is predominantly focusing its investments on the major
U.S. markets, including Arizona, California, Florida,
Massachusetts, Missouri, and Michigan.
Red White & Bloom Brands Inc. Investor and
Media RelationsEdoardo Mattei, CFOIR@RedWhiteBloom.com947-225-0503,
x.1003
Visit us on the web: www.redwhitebloom.com
Follow us on social media:
@rwbbrands
@redwhitebloombrands
@redwhitebloombrands
About Aleafia Health Inc.
Aleafia is a federally licensed Canadian
cannabis company offering cannabis products in Canadian adult-use
and medical markets and in select international markets, including
Australia and Germany. Aleafia operates a virtual medical cannabis
clinic staffed by physicians and nurse practitioners which provide
health and wellness services across Canada.
Aleafia owns three licensed cannabis production
facilities and operates a strategically located distribution centre
all in the province of Ontario, including the largest, outdoor
cannabis cultivation facility in Canada. Aleafia produces a diverse
portfolio of cannabis and cannabis derivative products including
dried flower, pre-roll, milled, vapes, oils, capsules, edibles,
sublingual strips and topicals.
For Aleafia Investor & Media Relations
Matthew Sale, CFO IR@Aleafiahealth.com LEARN
MORE: www.AleafiaHealth.com
Cautionary Note Regarding
Forward-Looking Information
This news release contains “forward-looking
information” and “forward-looking statements” (collectively,
“forward-looking statements”) within the meaning of the applicable
Canadian securities legislation. All statements, other than
statements of historical fact, are forward-looking statements and
are based on expectations, estimates and projections as at the date
of this news release. Any statement that involves discussions with
respect to predictions, expectations, beliefs, plans, projections,
objectives, assumptions, future events or performance (often but
not always using phrases such as “expects”, or “does not expect”,
“is expected”, “anticipates” or “does not anticipate”, “plans”,
“budget”, “scheduled”, “forecasts”, “estimates”, “believes” or
“intends” or variations of such words and phrases or stating that
certain actions, events or results “may” or “could”, “would”,
“might” or “will” be taken to occur or be achieved) are not
statements of historical fact and may be forward-looking
statements.
In this news release, forward-looking statements
relate to, among other things, statements regarding the
consideration of strategic options by each of Aleafia and RWB
following the mutual termination of the Letter Agreement and RWB’s
exercise of rights following Aleafia’s breach of certain covenants
under the Aleafia Senior Secured Loan Agreement. These
forward-looking statements are not guarantees of future results and
involve risks and uncertainties that may cause actual results to
differ materially from the potential results discussed in the
forward-looking statements.
Risks and uncertainties that may cause such
differences include but are not limited to: the possibility that
legal proceedings may be instituted against the Company, Aleafia
and/or others and the outcome of such proceedings; and other risks
inherent in the cannabis industry. The dedication of substantial
resources of RWB and Aleafia to the Proposed Transaction and to
strategic options following its termination could have a material
adverse impact on each of RWB’s and Aleafia’s share price, its
current business relationships and on the current and future
operations, financial condition, and prospects of each of the RWB
and Aleafia.
Aleafia Health (TSX:AH.DB)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Aleafia Health (TSX:AH.DB)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024